Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Tharimmune Inc.
THARCurrent price
2.43 USD
-0.4 USD (-14.13%)
Last closed
2.8 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 090 164 USD
Yield for 12 month
-96.76 %
1Y
3Y
5Y
10Y
15Y
THAR
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics; and Washington University in St. Louis for the rights to develop and commercialize technology related to multiple hybridomas and antibodies directed specifically towards human HER2. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey. Address: 1200 Route 22 East, Bridgewater, NJ, United States, 08807
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4 USDP/E ratio
0.1301Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures THAR
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
0.1301
Return On Assets TTM
-88.45 %
PEG Ratio
–
Return On Equity TTM
-181.81 %
Wall Street Target Price
4 USD
Revenue TTM
–
Book Value
6.11 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
20.67 USD
Diluted Eps TTM
20.67 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics THAR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History THAR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
28.05.2024
Dividend Date
–
Stock Valuation THAR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
0.1301
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-6.318
Price Book MRQ
0.4616
Financials THAR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators THAR
For 52 weeks
1.84 USD
101.25 USD
50 Day MA
2.54 USD
Shares Short Prior Month
36 570
200 Day MA
4.34 USD
Short Ratio
0.37
Shares Short
17 697
Short Percent
1.56 %
BeatStart